Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | NPC1 | O15118 | 4/20 | 1.00 |
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | PAX8 | Q06710 | 2/20 | 1.00 |
| ▸ | AHR | P35869 | 4/20 | 0.78 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.78 |
| ▸ | FYN | P06241 | 1/20 | 0.78 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.67 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.67 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.67 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beta-Naphthoflavone SCHEMBL43538 | 0.88 | ABCG2 (1.00) | TDP1NPC1RAB9APAX8AHR | |
| Beta-Naphthoflavone SCHEMBL29357406 | 0.88 | ABCG2 (1.00) | TDP1NPC1RAB9APAX8AHR | |
| Beta-Naphthoflavone SCHEMBL29881204 | 0.88 | ABCG2 (1.00) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL15854766 | 0.86 | TDP1 (1.00) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL15397111 | 0.86 | AHR (0.78) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL29361866 | 0.85 | TDP1 (0.74) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL25109125 | 0.82 | AHR (0.72) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL7116289 | 0.82 | ABCG2 (1.00) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL15397001 | 0.82 | AHR (0.72) | TDP1NPC1RAB9APAX8AHR | |
| SCHEMBL22525848 | 0.82 | AHR (0.72) | TDP1NPC1RAB9APAX8AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842721-B2 | Composition for treating cancer cells and synthetic method for the same | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2010-11-30 | — | — | US | disclosed |
| US-20090054516-A1 | COMPOSITION FOR TREATING CANCER CELLS AND SYNTHETIC METHOD FOR THE SAME | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2009-02-26 | — | — | US | disclosed |
| EP-1980248-A1 | Composition for treating cancer cells and synthetic method for the same | Kaohsiung Medical University (TW) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007083904-A1 | C-KIT ACTIVATION INHIBITOR, SKIN WHITENING COMPOUND AND COMPOSITION FOR SKIN WHITENING CONTAINING THE SAME | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054516-A1 | COMPOSITION FOR TREATING CANCER CELLS AND SYNTHETIC METHOD FOR THE SAME | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HK2, HCCS | TDP1 3943/4885NPC1 1101/4885RAB9A 1332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.